CLYM
Climb Bio, Inc.
NASDAQ · Healthcare · Biotechnology · US
$14.05
−0.07%Next report
Analyst consensus
- Next report date
- Nov 11, 2026
- EPS estimate
- -$0.19
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$0.18
- EPS estimate
- -$0.21
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 3
- EPS misses (12Q)
- 7
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -3.4%
- Revenue beats (12Q)
- —
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $27
- PT range
- $20 – $32
- Analysts
- 7
7 Buy0 Hold0 Sell
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.21 | -$0.18 | Beat 14.00% | — |
| May 7, 2026 | -$0.26 | -$0.20 | Beat 23.08% | — |
| Mar 5, 2026 | -$0.20 | -$0.26 | Miss -31.78% | — |
| Nov 6, 2025 | -$0.16 | -$0.19 | Miss -18.75% | — |
| May 14, 2025 | -$0.15 | -$0.31 | Miss -106.67% | — |
| Mar 25, 2025 | -$0.15 | -$0.13 | Beat 13.33% | — |
| Aug 14, 2024 | — | -$1.81 | — | — |
| May 15, 2024 | — | -$0.06 | — | — |
| Dec 31, 2023 | -$0.13 | -$0.13 | Miss -2.55% | — |
| Sep 30, 2023 | -$0.14 | -$0.15 | Miss -4.70% | — |
| Jun 30, 2023 | -$0.16 | -$0.19 | Miss -21.55% | — |
| Mar 31, 2023 | -$0.25 | -$0.84 | Miss -236.00% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026